



ADLM 2026 Explores Diabetes Milestones, Space Diagnostics, Alzheimer’s–Down Syndrome Links, and Cancer Advances
Five plenary sessions anchor ADLM's 2026 scientific program, highlighting advances spanning diabetes care, space diagnostics, neurodegenerative disease, cervical cancer screening, and cancer biomarkers. More...24 Jul 2026

Bringing laboratory diagnostics to space
At ADLM 2026, NASA laboratory director Kathleen McMonigal, MD, will discuss how clinical testing and medical monitoring help protect astronauts from the unique health risks of space travel during missions to the International Space Station and beyond. More...30 Jun 2026

Measuring what matters: advancing diversity, equity, and inclusion in lab medicine
An ADLM 2026 session will explore practical, evidence-based strategies for advancing diversity, equity, and inclusion in clinical laboratories to strengthen workforce culture, improve retention, and support more equitable patient care. More...30 Jun 2026

Academy guidance on data analytics: Preparing clinical labs for a data-driven future
A new ADLM guidance document and upcoming 2026 session aim to help clinical laboratories at any stage of digital transformation build effective data analytics programs, emphasizing accessible tools, strong infrastructure, and the critical role of data in advancing AI and patient care. More...30 Jun 2026








